Jayson Bedford
Stock Analyst at Raymond James
(4.66)
# 810
Out of 4,504 analysts
724
Total ratings
59.8%
Success rate
8.8%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DXCM DexCom | Maintained: Buy | $81 → $91 | $74.96 | +21.40% | 75 | Jun 8, 2026 | |
| PODD Insulet | Maintained: Buy | $263 → $216 | $161.28 | +33.93% | 46 | Jun 8, 2026 | |
| TFX Teleflex | Maintained: Buy | $128 → $150 | $135.73 | +10.51% | 13 | May 8, 2026 | |
| MMSI Merit Medical Systems | Maintained: Buy | $102 → $83 | $73.44 | +13.02% | 45 | May 1, 2026 | |
| AXGN Axogen | Maintained: Buy | $41 → $48 | $40.58 | +18.28% | 8 | Apr 29, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $124 → $88 | $44.77 | +96.56% | 76 | Mar 27, 2026 | |
| SYK Stryker | Upgraded: Buy | $418 | $329.78 | +26.75% | 4 | Jan 6, 2026 | |
| ZBH Zimmer Biomet Holdings | Downgraded: Hold | n/a | $91.34 | - | 9 | Jan 6, 2026 | |
| EW Edwards Lifesciences | Upgraded: Buy | $96 | $92.21 | +4.11% | 30 | Nov 3, 2025 | |
| ISRG Intuitive Surgical | Maintained: Buy | $592 → $603 | $406.78 | +48.24% | 15 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $19.56 | -2.86% | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $141 → $146 | $93.93 | +55.43% | 84 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $164 → $209 | $256.98 | -18.67% | 68 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $83.87 | - | 29 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $187 → $180 | $154.42 | +16.57% | 59 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $5.38 | - | 26 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $22.62 | - | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $18.79 | - | 29 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $151.94 | n/a | 12 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.06 | n/a | 16 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $15.41 | n/a | 17 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $13 | $12.79 | n/a | 41 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0002 | n/a | 12 | Jul 23, 2019 |
DexCom
Jun 8, 2026
Maintained: Buy
Price Target: $81 → $91
Current: $74.96
Upside: +21.40%
Insulet
Jun 8, 2026
Maintained: Buy
Price Target: $263 → $216
Current: $161.28
Upside: +33.93%
Teleflex
May 8, 2026
Maintained: Buy
Price Target: $128 → $150
Current: $135.73
Upside: +10.51%
Merit Medical Systems
May 1, 2026
Maintained: Buy
Price Target: $102 → $83
Current: $73.44
Upside: +13.02%
Axogen
Apr 29, 2026
Maintained: Buy
Price Target: $41 → $48
Current: $40.58
Upside: +18.28%
Boston Scientific
Mar 27, 2026
Maintained: Buy
Price Target: $124 → $88
Current: $44.77
Upside: +96.56%
Stryker
Jan 6, 2026
Upgraded: Buy
Price Target: $418
Current: $329.78
Upside: +26.75%
Zimmer Biomet Holdings
Jan 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $91.34
Upside: -
Edwards Lifesciences
Nov 3, 2025
Upgraded: Buy
Price Target: $96
Current: $92.21
Upside: +4.11%
Intuitive Surgical
Oct 22, 2025
Maintained: Buy
Price Target: $592 → $603
Current: $406.78
Upside: +48.24%
Oct 20, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $19.56
Upside: -2.86%
Oct 16, 2025
Maintained: Buy
Price Target: $141 → $146
Current: $93.93
Upside: +55.43%
Oct 15, 2025
Maintained: Buy
Price Target: $164 → $209
Current: $256.98
Upside: -18.67%
Aug 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $83.87
Upside: -
Aug 8, 2025
Maintained: Buy
Price Target: $187 → $180
Current: $154.42
Upside: +16.57%
Aug 8, 2025
Reiterated: Sell
Price Target: n/a
Current: $5.38
Upside: -
Aug 1, 2025
Maintained: Hold
Price Target: n/a
Current: $22.62
Upside: -
Aug 1, 2025
Maintained: Hold
Price Target: n/a
Current: $18.79
Upside: -
May 2, 2025
Downgraded: Hold
Price Target: n/a
Current: $151.94
Upside: n/a
Nov 16, 2023
Downgraded: Hold
Price Target: n/a
Current: $15.06
Upside: n/a
May 4, 2023
Maintained: Hold
Price Target: n/a
Current: $15.41
Upside: n/a
Apr 17, 2023
Maintained: Buy
Price Target: $14 → $13
Current: $12.79
Upside: n/a
Jul 23, 2019
Downgraded: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a